5min chapter

FYI - For Your Innovation cover image

The Gene-Editing Revolution with Verve Therapeutics

FYI - For Your Innovation

CHAPTER

The Challenge of Delivery of a Lipidano Particle in the Liver

A and g ptal three, the monoclonal a body from regeneron, is approved now for homo zagus f homosagus fh. There's a unique patient population for that therapy. And what we've been able to do over the last couple of years is am get high efficiency liver editing ad a doses closer to half a mit per co for one mit per cop. We actually think this galnac l and p that we've been working on, we've shown now that it works in wild ti hen tinis well and and andyet, we think it's going to be useful, a useful delivery tool for for our brograms.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode